| 发明名称 |
THERAPEUTIC FUSION PROTEIN |
| 摘要 |
The invention relates to a fusion protein comprising an antibody directed to Aβ, a monovalent binding entity which binds to a blood brain barrier receptor and a neprilysin. |
| 申请公布号 |
US2016168253(A1) |
申请公布日期 |
2016.06.16 |
| 申请号 |
US201414907173 |
申请日期 |
2014.07.30 |
| 申请人 |
HOFFMANN-LA ROCHE INC. |
发明人 |
Bohrmann Bernd;Freskgard Per-Ola;Knoetgen Hendrik;Niewoehner Jens |
| 分类号 |
C07K16/28;C12N9/64;C07K16/18 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A fusion protein comprising, an antibody directed to Aβ, a monovalent binding entity which binds to a blood brain barrier receptor and a neprilysin moiety. |
| 地址 |
Nutley NJ US |
